vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Bank of Marin Bancorp (BMRC). Click either name above to swap in a different company.

Bank of Marin Bancorp is the larger business by last-quarter revenue ($34.1M vs $23.1M, roughly 1.5× ADC Therapeutics SA). Over the past eight quarters, Bank of Marin Bancorp's revenue compounded faster (23.3% CAGR vs 13.7%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

American River Bank was a community bank founded in 1983 by Robert H. Daneke, who served as first president and CEO, and Bill L. Withrow, the first Chairman of the Board, and served the Greater Sacramento area in California. As of 2019, It operated ten branches in Northern CA. American River Bank which offered both business and personal financial services and was a wholly owned subsidiary of American River Bankshares.

ADCT vs BMRC — Head-to-Head

Bigger by revenue
BMRC
BMRC
1.5× larger
BMRC
$34.1M
$23.1M
ADCT
Faster 2-yr revenue CAGR
BMRC
BMRC
Annualised
BMRC
23.3%
13.7%
ADCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ADCT
ADCT
BMRC
BMRC
Revenue
$23.1M
$34.1M
Net Profit
$8.5M
Gross Margin
Operating Margin
-77.7%
Net Margin
24.9%
Revenue YoY
36.4%
Net Profit YoY
74.5%
EPS (diluted)
$0.04
$0.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
BMRC
BMRC
Q1 26
$34.1M
Q4 25
$23.1M
$27.0M
Q3 25
$15.8M
$30.9M
Q2 25
$18.1M
$10.3M
Q1 25
$17.4M
$27.8M
Q4 24
$16.9M
$22.2M
Q3 24
$18.0M
$27.2M
Q2 24
$17.0M
$22.5M
Net Profit
ADCT
ADCT
BMRC
BMRC
Q1 26
$8.5M
Q4 25
$-39.5M
Q3 25
$-41.0M
$7.5M
Q2 25
$-56.6M
$-8.5M
Q1 25
$-38.6M
$4.9M
Q4 24
$6.0M
Q3 24
$-44.0M
$4.6M
Q2 24
$-36.5M
$-21.9M
Operating Margin
ADCT
ADCT
BMRC
BMRC
Q1 26
Q4 25
-77.7%
-212.6%
Q3 25
-196.6%
31.1%
Q2 25
-244.1%
-108.8%
Q1 25
-163.5%
23.3%
Q4 24
-191.8%
43.5%
Q3 24
-197.4%
25.7%
Q2 24
-170.5%
-153.0%
Net Margin
ADCT
ADCT
BMRC
BMRC
Q1 26
24.9%
Q4 25
-146.5%
Q3 25
-260.1%
24.3%
Q2 25
-313.2%
-82.9%
Q1 25
-221.8%
17.5%
Q4 24
27.1%
Q3 24
-244.1%
16.8%
Q2 24
-214.6%
-97.5%
EPS (diluted)
ADCT
ADCT
BMRC
BMRC
Q1 26
$0.53
Q4 25
$0.04
$-2.48
Q3 25
$-0.30
$0.47
Q2 25
$-0.50
$-0.53
Q1 25
$-0.36
$0.30
Q4 24
$-0.26
$0.38
Q3 24
$-0.42
$0.28
Q2 24
$-0.38
$-1.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
BMRC
BMRC
Cash + ST InvestmentsLiquidity on hand
$261.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$394.5M
Total Assets
$323.1M
$3.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
BMRC
BMRC
Q1 26
Q4 25
$261.3M
Q3 25
$234.7M
Q2 25
$264.6M
Q1 25
$194.7M
Q4 24
$250.9M
Q3 24
$274.3M
Q2 24
$300.1M
Stockholders' Equity
ADCT
ADCT
BMRC
BMRC
Q1 26
$394.5M
Q4 25
$-185.8M
$394.7M
Q3 25
$-238.2M
$443.8M
Q2 25
$-199.2M
$438.5M
Q1 25
$-238.2M
$439.6M
Q4 24
$-202.6M
$435.4M
Q3 24
$-171.9M
$437.0M
Q2 24
$-131.7M
$434.9M
Total Assets
ADCT
ADCT
BMRC
BMRC
Q1 26
$3.9B
Q4 25
$323.1M
$3.9B
Q3 25
$289.8M
$3.9B
Q2 25
$321.6M
$3.7B
Q1 25
$272.5M
$3.8B
Q4 24
$322.0M
$3.7B
Q3 24
$349.1M
$3.8B
Q2 24
$371.8M
$3.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
BMRC
BMRC
Operating Cash FlowLast quarter
$-31.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
BMRC
BMRC
Q1 26
Q4 25
$-31.1M
$39.1M
Q3 25
$-29.6M
$12.5M
Q2 25
$-24.1M
$8.0M
Q1 25
$-56.3M
$4.9M
Q4 24
$-21.9M
$28.4M
Q3 24
$-25.0M
$9.9M
Q2 24
$-32.8M
$3.4M
Free Cash Flow
ADCT
ADCT
BMRC
BMRC
Q1 26
Q4 25
$37.3M
Q3 25
$12.1M
Q2 25
$7.1M
Q1 25
$-56.6M
$4.6M
Q4 24
$-21.9M
$27.8M
Q3 24
$-25.3M
$9.8M
Q2 24
$-32.9M
$3.4M
FCF Margin
ADCT
ADCT
BMRC
BMRC
Q1 26
Q4 25
138.1%
Q3 25
39.0%
Q2 25
68.7%
Q1 25
-325.2%
16.6%
Q4 24
-129.8%
125.7%
Q3 24
-140.2%
36.0%
Q2 24
-193.0%
15.0%
Capex Intensity
ADCT
ADCT
BMRC
BMRC
Q1 26
Q4 25
0.0%
6.7%
Q3 25
0.0%
1.3%
Q2 25
0.0%
9.4%
Q1 25
1.5%
1.1%
Q4 24
0.5%
2.3%
Q3 24
1.2%
0.4%
Q2 24
0.2%
0.4%
Cash Conversion
ADCT
ADCT
BMRC
BMRC
Q1 26
Q4 25
Q3 25
1.66×
Q2 25
Q1 25
1.01×
Q4 24
4.73×
Q3 24
2.16×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

BMRC
BMRC

Net Interest Income$30.3M89%
Noninterest Income$3.8M11%

Related Comparisons